Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer
• Esophageal Cancer
• Lymphoma
• Multiple Myeloma
• Ovarian Cancer
• Prostate Cancer
• Small Cell Lung Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Multiple Myeloma | Phase 3 | Status: COMPLETED